Protein switch behind stubborn lung cancers offers new treatment target

Scientists have uncovered a molecular “on–off” switch that helps lung adenocarcinoma—the most common form of lung cancer—grow and spread. The discovery pinpoints the protein calcyclin‑binding protein (CACYBP) as a key driver of tumor activity and suggests that blocking it could improve outcomes for patients who fail to benefit from current drugs. The study is published in the journal Biomolecules and Biomedicine.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup